Navigation Links
Medrio, a Leading EDC Provider for Clinical Research, Announces eClinical Networking and Dinner Seminar
Date:10/2/2013

San Francisco, CA (PRWEB) October 02, 2013

Medrio, a leading provider of Electronic Data Capture and eClinical tools, announced they will be hosting their first annual eClinical Networking and Dinner Seminar in partnership with Peter Shabe, CEO and President of Advance Research Associates, on October 17th, 2013.

“I’m excited to announce our first eClinical Dinner Seminar, featuring Peter Shabe of Advance Research Associates who will be sharing best practices and expertise on the Role of Statistics in Clinical Trials,” said Scott Weidley, Sr. Senior Director of Sales and Marketing. “Medrio strives to provide valuable resources to the clinical research community and I’m looking forward to hosting this event.”

The role of statistics in a clinical trial provides a structured process to quantify the safety and efficacy of an investigational product and compare one to another with a reliable and reproducible result.

Peter will provide a brief, concise, and entertaining overview of statistics by guiding us through four basic steps: 1) collecting data, 2) summarizing data, 3) performing statistical analysis of results, and 4) learning how to generalize results to the population being studied.

About Medrio
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit http://www.medrio.com.

About Peter Shabe
Peter Shabe has over 25 years of experience in Phase I - IV clinical trials of drug and medical device development. His expertise includes SAS for developing data management and data analysis applications, as well as analyzing and reporting clinical data.

In 1996, Peter founded his own company, Advance Research Associates, where he manages a team of bio statisticians and data management professionals for clients worldwide. For more information, visit http://www.advanceresearch.com.

Read the full story at http://www.prweb.com/releases/eClinicalsoftware/eClinicaltools/prweb11185447.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Independent Research Shows That Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Continues to Achieve Exceptional Scores in Customer Satisfaction
2. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
3. Diabetes drug could treat leading cause of blindness
4. Pneumonia and preterm birth complications are the leading causes of childhood death
5. Leading health care quality expert is 2012 AcademyHealth Distinguished Investigator
6. Dr. Edmund Lipskis & Dr. Lynn Lipskis Will be Featured On New National Television Show Entitled: “Leading The Field” World Class Experts Share Their Tips & Advice
7. ACR: Medical imaging study in health affairs incomplete and potentially misleading
8. Poorly-performing hand implants unacceptable says leading medical journal
9. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
10. WSU researchers discover mechanism leading from trichomoniasis to prostate cancer
11. Report: Cancer now leading cause of death in US hispanics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... An August 3rd article on Reuters covers ... of a report in JAMA (the Journal of the American Medical Association). The study found ... to achieve BMIs under 30, when compared to patients with lower BMIs. At present, weight ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... list represents a unique look at the most successful companies within the American economy’s ...
(Date:8/16/2017)... Brentwood, TN (PRWEB) , ... August 16, 2017 ... ... market-leading dermatology practice partnerships through affiliations and de novo development, today announced ... practice. , Cumberland Skin Surgery and Dermatology, with offices in both Hermitage ...
(Date:8/16/2017)... ... 16, 2017 , ... Paul Vitenas, MD, FACS , is honored to ... annual list identifies the nation’s top physicians, in a variety of specialties. This marks ... top of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection Control ... cycle, both between patient procedures and before storage, is a requisite practice crucial ... to the prevention of disease transmission and nosocomial infection as cleaning and HLD.” ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: